ACRF funded scientist delivers a new way to hit leukemia Posted on July 7, 2009February 25, 2018 by Carly du Toit An Australian researcher funded by the Australian Cancer Research Foundation (ACRF) is part of the team which has developed a new approach to the treatment of acute leukemia. The antibody used in the new research was first created by ACRF funded Professor Angel Lopez now at the Centre for Cancer Biology in Adelaide, South Australia. The research targets myeloid leukemia (AML), one of the most aggressive forms of leukemia. Quoted in the July 2 issue of prominent research journal, Stem Cell, Associate Professor Richard Lock, Head of the Leukemia Biology Program at Children’s Cancer Institute Australia for Medical Research (CCIA) and the University of New South Wales – who have also received major funding from ACRF – said the findings were an exciting development towards finding more effective treatments for this rare but deadly disease. Continue reading “ACRF funded scientist delivers a new way to hit leukemia”
